spend a great deal of time deciding how many calls to make to each individual physician and when to make those calls.
Veteran pharmaceutical investigators Sack and Mundy document in stunning detail the efforts of the drug companies
over the next year--not to pull their products from the shelves, but to shield their study from investigators and deny that such a link exists.
Pappert said the 42-page lawsuit, filed today in Commonwealth Court, accuses the drug companies
of participating in an unfair and deceptive marketing scheme and conspiracy that provided improper incentives to medical providers to gain market share.
I have little space in my capitalistic heart to spend pining for the poor, vilified drug companies
still rely on thousands of sales agents to persuade doctors to use their drugs, said Ed Mathers, vice president consumer health-care marketing for Glaxo Wellcome.
However, drug companies
are facing an unprecedented number of challenges in maintaining revenue growth: fewer drugs are being approved, a wide number of blockbusters are facing patent expiry, and payers are implementing stringent cost-containment policies in the face of sky-rocketing healthcare costs.
Starting with drug companies
seeking a spare hand for some unusual tasks, outsourcing has been practiced for decades and now expanded to include all types of externalization, including close collaboration, networked partnership, open innovation, and even technology licensing.
When the Obama administration was working on health care reform, the drug companies
reached a deal with the White House to fend off legislation granting government the power to negotiate drug prices.
Doctors who speak for drug companies
and doctors who receive their medical education from such speakers stray dangerously away from this ideal.
They charged that drug companies
, out of greed, were refusing to replace the pseudoephedrine in their cold medicines, a methamphetamine precursor, with the decongestant phenylephrine, which is useless in producing meth.
, editorialized the paper, "toss out several unconvincing arguments against allowing Medicare to negotiate with them.
This is the impact of the constantly unfavorable comments that the major drug companies
are subject to.